KINDERÄRZTE.SCHWEIZ 4/2020

26 FORTB I LDUNG: THEMENHEFTTE I L 04 / 2020 K I N D E R Ä R Z T E . SCHWEIZ LITERATUR: 1. Levin M. Childhood Multisystem Inflammatory Syndrome – A New Challenge in the Pandemic. N Engl J Med. 2020;383(4):393–395. 2. Zimmermann P, Curtis N. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. The Pediatric Infectious Disease Journal. 2020: In press. 3. Waterfield T, Watson C, Moore R, Ferris K, Tonry C, Watt AP, et al. Seroprevalence of SARS-CoV-2 antibodies in chil- dren – A prospective multicentre cohort study. medRxiv. 2020:2020.2008.2031.20183095. 4. Zimmermann P, Curtis N. Coronavirus Infections in Children Includ- ing COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J. 2020;39(5):355–368. 5. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA pediatrics. 2020. 6. Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003;361(9370):1701–1703. 7. Leung CW, Kwan YW, Ko PW, Chiu SS, Loung PY, Fong NC, et al. Severe acute respiratory syndrome among children. Pediatrics. 2004;113(6):e535–543. 8. Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syn- drome coronavirus disease is rare in children: An update from Sau- di Arabia. World J Clin Pediatr. 2016;5(4):391–396. 9. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clinical mi- crobiology reviews. 2010;23(1):74–98. 10. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. 11. Coronavirus Disease 2019 in Children – United States, February 12 –April 2, 2020. MMWR Morbidity and mortality weekly report. 2020;69(14):422–426. 12. Parri N, Lenge M, Buonsenso D. Children with COVID-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020;383(2):187– 190. 13. Posfay-Barbe KM, Wagner N, Gauthey M, Moussaoui D, Loevy N, Diana A, et al. COVID-19 in Children and the Dynamics of Infec- tion in Families. Pediatrics. 2020;146(2). 14. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infec- tion in Children. N Engl J Med. 2020. 15. Viner RM, Mytton OT, Bonell C, Melendez-Torres GJ, Ward JL, Hud- son L, et al. Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults: a systematic review and meta-analysis. medRxiv. 2020:2020.2005.2020.20108126. 16. Madewell ZJ, Yang Y, Longini IM, Halloran ME, Dean NE. Household transmission of SARS-CoV-2: a systemat- ic review and meta-analysis of secondary attack rate. medRxiv. 2020:2020.2007.2029.20164590. 17. Lei H, Xu X, Xiao S, Wu X, Shu Y. Household transmission of COVID- 19-a systematic review and meta-analysis. J Infect. 2020. 18. Jones TC, Mühlemann B, Veith T, Biele G, Zuchowski M, Hoff- mann J, et al. An analysis of SARS-CoV-2 viral load by patient age. medRxiv. 2020:2020.2006.2008.20125484. 19. Baggio S, L’Huillier AG, Yerly S, Bellon M, Wagner N, Rohr M, et al. SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19. Clin Infect Dis. 2020. 20. Heald-Sargent T, Muller WJ, Zheng X, Rippe J, Patel AB, Kociol- ek LK. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Pa- tients With Mild to Moderate Coronavirus Disease 2019 (COVID- 19). JAMA pediatrics. 2020. 21. L’Huillier AG, Torriani G, Pigny F, Kaiser L, Eckerle I. Culture-Compe- tent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Chil- dren, and Adolescents. Emerging infectious diseases. 2020;26(10). 22. Park YJ, Choe YJ, Park O, Park SY, Kim Y-M, Kim J, et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerging Infectious Disease journal. 2020;26(10). 23. Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, et al. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomat- ic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. JAMA Intern Med. 2020. 24. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS- CoV-2 Viral Load in Upper Respiratory Specimens of Infected Pa- tients. N Engl J Med. 2020;382(12):1177–1179. 25. Hurst JH, Heston SM, Chambers HN, Cunningham HM, Price MJ, Suarez L, et al. SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. medRxiv. 2020:2020.2008.2018.20166835. 26. COVID-19 in schools – the experience in NSW. http://www.ncirs. org.au/covid-19-in-schools. Updated 26 April 2020. Accessed 04 Mai 2020. 27. Children and COVID-19. https://www.rivm.nl/en/novel-coronavirus- covid-19/children-and-covid-19. Updated 29 April 2020. Accessed 04 Mai 2020. 28. Ladhani S. Prospective active national surveillance of preschools and primary schools for SARS-CoV-2 infection and transmission in England, June 2020 (sKIDs COVID-19 surveillance in school KIDs). https://assetspublishingservicegovuk/government/uploads/system/ uploads/attachment_data/file/914700/sKIDs_Phase1Report_ 01sep2020pdf. 2020. 29. Burgess S, Ponsford MJ, Gill D. Are we underestimating seropreva- lence of SARS-CoV-2? BMJ (Clinical research ed). 2020;370:m3364. 30. To KK-W, Cheng VC-C, Cai J-P, Chan K-H, Chen L-L, Wong L-H, et al. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study. The Lancet Microbe. 2020;1(3):e111-e118. 31. Laxminarayan R, Wahl B, Dudala SR, Gopal K, Mohan C, Neelima S, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science (New York, NY). 2020:eabd7672. 32. Kriemler S, Puhan M. https://www.ciao-corona.ch/resultate. 2020. 33. Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of Child- hood Disease. 2020;In press. 34. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-re- activity with SARS-CoV. Nature communications. 2020;11(1):1620. 35. Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikke- ma L. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflamma- tory programs in putative target cells. Biorxiv. 2020 :https://doi.org /10.1101/2020.1104.1119.049254. 36. Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of An- giotensin-Converting Enzyme 2 in Children and Adults. Jama. 2020;323(23):2427–2429. 37. Huang SH, Su MC, Tien N, Huang CJ, Lan YC, Lin CS, et al. Epi- demiology of human coronavirus NL63 infection among hospital- ized patients with pneumonia in Taiwan. J Microbiol Immunol In- fect. 2017;50(6):763–770. 38. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin- converting enzyme 2 protects from severe acute lung failure. Na- ture. 2005;436(7047):112–116. 39. Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, et al. Angiotensin-convert- ing enzyme 2 protects from lethal avian influenza A H5N1 infec- tions. Nature communications. 2014;5:3594. 40. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374. 41. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417–1418. 42. Ignjatovic V, Mertyn E, Monagle P. The coagulation system in chil- dren: developmental and pathophysiological considerations. Semin Thromb Hemost. 2011;37(7):723–729. 43. Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: The co- nundrum. Diabetes Res Clin Pract. 2020;162:108132. 44. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID- 19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.